Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
Individualized therapies targeting epidermal growth factor receptor (EGFR) mutations show promises for the treatment of non small-cell lung carcinoma (NSCLC). However, disease progression almost invariably occurs 1 year after tyrosine kinase inhibitor (TKI) treatment. The most prominent mechanism of...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
De Gruyter
2016-01-01
|
| coleção: | Open Medicine |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1515/med-2016-0014 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|